JENNA COOPER: Open Payments
NPI 1427535079 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 68 payments from 15 companies in 2025. Trend: 2023 $1,038 · 2024 $1,407 · 2025 $1,450
Food & beverage: $1,351Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $339 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $328 |
| UCB, Inc. | 8 | $183 |
| Amgen Inc. | 11 | $155 |
| Janssen Biotech, Inc. | 4 | $149 |
| Mallinckrodt Hospital Products Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Organon LLC | 4 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Incyte Corporation | 1 | $29 |
Products named: ILUMYA, RINVOQ, Bimzelx, Otezla, TREMFYA, SKYRIZI, ACTHAR, Sotyktu.
Industry payments across MS — which companies pay providers there.
